Loading insider details...
Latest Form 4 (Mar 27, 2026): Grant/Award of 50,000 GANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 27, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 50,000 | n/a |
| Mar 22, 2025 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 50,000 | n/a |
| Mar 26, 2024 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 50,000 | n/a |
| Mar 27, 2023 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |